Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital

Pediatric Blood and Cancer

Volumn 51, Issue 1, 2008, Pages 82-85

  Raphael, Jean L ^a,d   Kamdar, Aditi ^b   Beavers, M Brooke ^a,c   Mahoney, Donald H ^a   Mueller, Brigitta U ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d Texas Children's Hospital   (United States)

Author keywords

Pediatrics; Quality improvement; Sickle cell disease; Vaso occlusive crisis

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CODEINE; HYDROCODONE; HYDROMORPHONE; INFUSION FLUID; MORPHINE; OPIATE; OXYCODONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CHILD CARE; DAY HOSPITAL; EMERGENCY CARE; FEMALE; HEMOGLOBIN SC DISEASE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYDRATION; INTRAVENOUS ADMINISTRATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PAIN; PAIN ASSESSMENT; PATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA; THALASSEMIA; TOTAL QUALITY MANAGEMENT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; DAY CARE; HOSPITALIZATION; HUMANS; OUTPATIENTS; PAIN; PAIN MEASUREMENT; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; VASCULAR DISEASES;

EID: 44149124896     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21483     Document Type: Article

References (23)

1. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
2. Stinson J, Naser B. Pain management in children with sickle cell disease. Paediatr Drugs 2003;5:229-241.
3. Houston-Yu P, Rana SR, Beyer B, et al. Frequent and prolonged hospitalizations: A risk factor for early mortality in sickle cell disease patients. Am J Haematol 2003;72:201-203.
4. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16.
5. Yang YM, Shah AK, Watson M, et al. Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. Public Health Rep 1995;110:80-86.
6. Panepinto JA, Brousseau DC, Hillery CA, et al. Variation in hospitalizations and hospital length of stay in children with vasoocclusive crises in sickle cell disease. Pediatr Blood Cancer 2005;44:182-186.
7. Steiner CA, Miller JL. Sickle cell disease patients in U.S. hospitals, 2004: Agency for healthcare research and quality; 2006. Report.
8. Ware MA, Hambleton I, Ochaya I, et al. Day-care management of sickle cell painful crisis in Jamaica: A model applicable elsewhere? Br J Haematol 1999;104:93-96.
9. Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: An approach for the management of uncomplicated painful crises. Blood 2000;95:1130-1136.
10. Wright J, Bareford D, Wright C, et al. Day case management of sickle pain: 3 years experience in a UK sickle cell unit. Br J Haematol 2004;126:878-880.
11. Chambers CT, Giesbrecht K, Craig KD, et al. A comparison of faces scales for the measurement of pediatric pain: Children's and parents' ratings. Pain 1999;83:25-35.
12. Oberlander TF, Gilbert CA, Chambers CT, et al. Biobehavioral responses to acute pain in adolescents with a significant neurologic impairment. Clin J Pain 1999;15:201-209.
13. Institute NC. 9/4/2007. Pain: Pharmacological Management http:// www.cancer.gov/cancertopics/pdq/supportivecare/pain/healthprofessional. Accessed 9/4/2007.
14. Patanwala AE, Duby J, Waters D, et al. Opioid conversions in acute care. Ann Pharmacother 2007;41:255-266.
15. Ballantyne JC. Chronic pain following treatment for cancer: The role of opioids. Oncologist 2003;8:567-575.
16. Pereira J, Lawlor P, Vigano A, et al. Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manage 2001;22:672-687.
17. Max M, Payne R, Edwards W, et al. Principles of analgesic use in the treatment of acute pain and cancer pain. Skokie, IL: American Pain Society; 1999.
18. Adewoye AH, Nolan V, McMahon L, et al. Effectiveness of a dedicated day hospital for management of acute sickle cell pain. Haematologica 2007;92:854-855.
19. Beyer JE. Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease. J Pain Symptom Manage 2000;19:63-72.
20. Eaton ML, Haye JS, Armstrong FD, et al. Hospitalizations for painful episodes: Association with school absenteeism and academic performance in children and adolescents with sickle cell anemia. Issues Compr Pediatr Nurs 1995;18:1-9.
21. Shapiro BS, Benjamin LJ, Payne R, et al. Sickle cell-related pain: Perceptions of medical practitioners. J Pain Symptom Manage 1997;14:168-174.
22. Maxwell K, Streetly A, Bevan D. Experiences of hospital care and treatment seeking for pain from sickle cell disease: Qualitative study. Br Med J (Clin Res Ed) 1999;318:1585-1590.
23. IOM. Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academies Press; 2001.